TALK. TEXT. SHARE. Trademark

Trademark Overview


On Tuesday, August 2, 2022, a trademark application was filed for TALK. TEXT. SHARE. with the United States Patent and Trademark Office. The USPTO has given the TALK. TEXT. SHARE. trademark a serial number of 97530188. The federal status of this trademark filing is REGISTERED as of Tuesday, January 16, 2024. This trademark is owned by Optiks Solutions, Inc. The TALK. TEXT. SHARE. trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Platform as a service (PAAS) featuring computer software platforms for IT Solutions for Healthcare, Medical Devices, pharmaceutical and biotech industries, namely, Mobile Application to Record Interactions with Healthcare Professionals, patients, healthcare organizations Including Physicians, Patients, Payers, Providers and Providing Representatives an Ability to View Media Content and Reports, Web and Mobile Portals For Patients to Find Information on Drugs and Connect with Pharma Companies, Web and Mobile Portals For Physicians to Find Information on Drugs and Connect with Pharma Companies, Mobile and Web Application to Providing Reporting and Analytics Capabilities Using Various Data Sources; Providing temporary use of non-downloadable cloud based software featuring computer software platforms for IT Solutions for Healthcare, Medical Devices pharmaceutical and biotech industries, namely, Sales Force Automation to log interactions with health care professionals including physicians, ...
talk. text. share.

General Information


Serial Number97530188
Word MarkTALK. TEXT. SHARE.
Filing DateTuesday, August 2, 2022
Status700 - REGISTERED
Status DateTuesday, January 16, 2024
Registration Number7281636
Registration DateTuesday, January 16, 2024
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesPlatform as a service (PAAS) featuring computer software platforms for IT Solutions for Healthcare, Medical Devices, pharmaceutical and biotech industries, namely, Mobile Application to Record Interactions with Healthcare Professionals, patients, healthcare organizations Including Physicians, Patients, Payers, Providers and Providing Representatives an Ability to View Media Content and Reports, Web and Mobile Portals For Patients to Find Information on Drugs and Connect with Pharma Companies, Web and Mobile Portals For Physicians to Find Information on Drugs and Connect with Pharma Companies, Mobile and Web Application to Providing Reporting and Analytics Capabilities Using Various Data Sources; Providing temporary use of non-downloadable cloud based software featuring computer software platforms for IT Solutions for Healthcare, Medical Devices pharmaceutical and biotech industries, namely, Sales Force Automation to log interactions with health care professionals including physicians, Patients, Payers, Providers, Customer Relationship Management application to manage Contacts, Accounts, Opportunities, Orders and other custom entities, Maintain operational customer master and integrate with other applications, Application to manage all phases of clinical trials including Site Management and Study Management, Application to provide patients with complete support during the course of therapy from the time of prescription including welcome call, Benefit Investigations, Trial Orders, Prior Authorization; Providing temporary use of online non-downloadable Analytics and Planning software providing advanced analytics using machine learning, Internet of Things (IoT), and artificial intelligence to support interactions between pharma, biotech, and med devices companies, physicians, payers, and providers; software as a service (SAAS) services featuring Analytics and Planning software providing advanced analytics using machine learning, Internet of Things (IoT), and artificial intelligence to support interactions between pharma/biotech/med devices companies, physicians, payers, and providers; Platform as a service (PAAS) featuring conversational artificial intelligence for call filtering, call monitoring, making audio and video calls, co-browse, SMS and email alerts, sales tracking, attribution measurement, marketing and sales optimization, and customer service to support interactions between pharmaceuticals, biotechnology, and medical devices companies, physicians, patients, payers, and providers, and other healthcare workers; Software as a Services (SAAS) featuring conversational artificial intelligence for call filtering, call monitoring, making audio and video calls, co-browse, SMS and email alerts, sales tracking, attribution measurement, marketing and sales optimization, and customer service to support interactions between pharmaceuticals, biotechnology, and medical devices companies, physicians, patients, payers, and providers, and other healthcare workers

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, August 23, 2022
Primary Code042
First Use Anywhere DateTuesday, May 10, 2022
First Use In Commerce DateTuesday, May 10, 2022

Trademark Owner History


Party NameOptiks Solutions, Inc
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressEdison, NJ 08837

Party NameOptiks Solutions, Inc
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressPISCATAWAY, NJ 08854

Trademark Events


Event DateEvent Description
Friday, May 19, 2023NON-FINAL ACTION E-MAILED
Friday, August 5, 2022NEW APPLICATION ENTERED
Tuesday, August 23, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, May 19, 2023ASSIGNED TO EXAMINER
Friday, May 19, 2023NON-FINAL ACTION WRITTEN
Friday, May 19, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Saturday, May 20, 2023NON-FINAL ACTION WRITTEN
Saturday, May 20, 2023NON-FINAL ACTION E-MAILED
Saturday, May 20, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, June 20, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, June 20, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, June 20, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, August 24, 2023APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
Tuesday, January 16, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, January 16, 2024REGISTERED-SUPPLEMENTAL REGISTER
Tuesday, June 25, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, June 25, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, June 25, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, June 25, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, June 25, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, January 22, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
Wednesday, January 17, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED